
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Epidemiology [H. G. S., G. A. C., E. L. G., M. J. S., W. C. W.] and Department of Nutrition, Harvard School of Public Health [G. A. C., E. L. G., M. J. S., W. C. W.], Boston, Massachusetts 02115; The Channing Laboratory, Department of Medicine, Brigham and Womens Hospital and Harvard Medical School, Boston, Massachusetts 02115 [H. G. S., G. A. C., E. L. G., M. J. S., W. C. W., C. S. F.]; Department of Adult Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115 [C. S. F.]; and Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland 20892 [D. S. M.]
Incidence rates for pancreatic cancer are consistently lower in women than in men. Previous studies suggest that reproductive factors, particularly parity, may reduce pancreatic cancer risk in women. We examined parity, breast feeding history, age at first birth, menstrual factors, and exogenous hormone use in relation to pancreatic cancer risk in a prospective cohort study of women. Information on parity and other reproductive factors was assessed by questionnaires in 1976 and updated biennially. Multivariate relative risks were adjusted for cigarette smoking, body mass index, diabetes, and height. During 22 years of follow-up (19761998), 115,474 women contributed 2.4 million years of person time, and 243 cases of pancreatic cancer were identified. Compared with nulliparous women, the relative risk of pancreatic cancer was 0.86 [95% confidence interval (CI), 0.551.36] for women with 12 births, 0.75 (95% CI, 0.481.17) for 34 births, and 0.58 (95% CI, 0.340.98) for those with
5 births after adjusting for other factors. An analysis for linear trend indicates a 10% reduction in risk for each birth (Ptrend = 0.008). Other reproductive factors and exogenous hormone use were not significantly related to pancreatic cancer risk. In this large prospective cohort of women, parity was associated significantly with a reduced risk of pancreatic cancer. Additional studies should examine the physiological or hormonal changes underlying pregnancy or childbirth that may explain this finding.
This article has been cited by other articles:
![]() |
J. B Greer and D. C Whitcomb Role of BRCA1 and BRCA2 mutations in pancreatic cancer Gut, May 1, 2007; 56(5): 601 - 605. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Nothlings, L. R. Wilkens, S. P. Murphy, J. H. Hankin, B. E. Henderson, and L. N. Kolonel Vegetable Intake and Pancreatic Cancer Risk: The Multiethnic Cohort Study Am. J. Epidemiol., January 15, 2007; 165(2): 138 - 147. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shen, P. Boffetta, J. H. Olsen, A. Andersen, K. Hemminki, E. Pukkala, E. Tracey, D. H. Brewster, M. L. McBride, V. Pompe-Kirn, et al. A Pooled Analysis of Second Primary Pancreatic Cancer Am. J. Epidemiol., March 15, 2006; 163(6): 502 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. McGrath, D. S. Michaud, and I. De Vivo Hormonal and Reproductive Factors and the Risk of Bladder Cancer in Women Am. J. Epidemiol., February 1, 2006; 163(3): 236 - 244. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Mondul, C. Rodriguez, E. J. Jacobs, and E. E. Calle Age at Natural Menopause and Cause-specific Mortality Am. J. Epidemiol., December 1, 2005; 162(11): 1089 - 1097. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Fesinmeyer, M. A. Austin, C. I. Li, A. J. De Roos, and D. J. Bowen Differences in Survival by Histologic Type of Pancreatic Cancer Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1766 - 1773. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Duell and E. A. Holly Reproductive and Menstrual Risk Factors for Pancreatic Cancer: A Population-based Study of San Francisco Bay Area Women Am. J. Epidemiol., April 15, 2005; 161(8): 741 - 747. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Helle, V. Lummaa, and J. Jokela Accelerated immunosenescence in preindustrial twin mothers PNAS, August 17, 2004; 101(33): 12391 - 12396. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |